Your browser doesn't support javascript.
loading
Optimal Nutrition Formulas for Patients Undergoing Surgery for Colorectal Cancer: A Bayesian Network Analysis.
Jiang, Xiao-Han; Chen, Xi-Jie; Wang, Xin-You; Chen, Yun-Zhi; Xie, Qin-Qin; Peng, Jun-Sheng.
Afiliación
  • Jiang XH; School of Nursing, Sun Yat-Sen University, Guangzhou, China.
  • Chen XJ; Guangdong Institute of Gastroenterology, the Sixth Affiliated Hospital, Sun Yat-sen University, Guangzhou, Guangdong, China.
  • Wang XY; Department of Colorectal Surgery, the Sixth Affiliated Hospital, Sun Yat-Sen University, Guangzhou, China.
  • Chen YZ; Guangdong Provincial Key Laboratory of Colorectal and Pelvic Floor Diseases, The Sixth Affiliated Hospital, Sun Yat-sen University, Guangzhou, China.
  • Xie QQ; Guangdong Institute of Gastroenterology, the Sixth Affiliated Hospital, Sun Yat-sen University, Guangzhou, Guangdong, China.
  • Peng JS; Department of Gastrointestinal Surgery, The Sixth Affiliated Hospital, Sun Yat-Sen University, Guangzhou, China.
Nutr Cancer ; 73(5): 775-784, 2021.
Article en En | MEDLINE | ID: mdl-32692267
ABSTRACT
Optimal nutrition formulas for colorectal cancer patients underwent surgery remains uncertainty. We constructed an indirect comparison study to assess comparative efficacy of different immunonutrition formulas and standard nutrition in colorectal cancer patients underwent surgery. PubMed, the Cochrane Library, EMBASE, ClinicalTrials.gov and Web of Science databases were searched to identify RCTs that compared immunonutrition with standard nutrition or different immunonutrition formulas. Data on length of hospital stays (LOS), infectious complications (IC), noninfectious complications (NIC) and anastomotic leakage (AL) were extracted from the included RCTs for Bayesian network analysis using a random-effect model. Twelve articles that included 1032 individuals were incorporated into this study. The indirect comparison confirmed the potential improvement of arginine-based immunonutrition on IC (odds ratios [OR] = 0.43, 95%confidence interval [CI] 0.17 to 0.95), glutamine on NIC (OR = 0.07 CI 0.00 to 0.78) and LOS (MD=-3.91 CI -6.33 to -1.69) and omega-3 polyunsaturated fatty acids on LOS (OR=-3.49 CI -5.46 to -1.00). Results indicated that glutamine had the highest probability of reducing complications and hospital stays. As for colorectal cancer patients underwent surgery, this indirect comparison suggested some superiority of glutamine. Future more RCTs with larger scale are required to provide evidence for the optimal immunonutrition formulas.
Asunto(s)

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Neoplasias Colorrectales / Nutrición Enteral Tipo de estudio: Prognostic_studies / Systematic_reviews Límite: Humans Idioma: En Revista: Nutr Cancer Año: 2021 Tipo del documento: Article País de afiliación: China

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Neoplasias Colorrectales / Nutrición Enteral Tipo de estudio: Prognostic_studies / Systematic_reviews Límite: Humans Idioma: En Revista: Nutr Cancer Año: 2021 Tipo del documento: Article País de afiliación: China